ATMP Horizon

Nordic HTA case detection

← Board

Provenge CONFIRMED

autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t) · Prostatic Neoplasms

Current stage: 4 · first detected 2026-06-25

Also known as: provenge

CompanyDendreon UK Ltd
ATC codeL03AX17
EU authorised2013-09-06 · 12 yr ago
Flags
EMA EPAR Evidence dossier ↗

Status timeline

DateBodyStatusStageSource
2026-06-25 EMA withdrawn 4 link
2026-06-30 EMA withdrawn 4 link
2026-07-07 EMA withdrawn 4 link
2026-07-14 EMA withdrawn 4 link
2026-07-21 EMA withdrawn 4 link
2026-07-28 EMA withdrawn 4 link
2026-08-04 EMA withdrawn 4 link
2026-08-05 EMA withdrawn 4 link
2026-08-05 EMA withdrawn 4 link
2026-08-11 EMA withdrawn 4 link
2026-08-18 EMA withdrawn 4 link